Automatic adjusting R-wave synchronization algorithm for atrial cardioversion and defibrillation

• US 7,561,913 B2
• Filed: 04/30/2003
• Issued: 07/14/2009
• Est. Priority Date: 04/30/2003
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Mehra, Rahul, Mongeon, Luc R.
• Primary Examiner(s): Sykes; Angela D
• Assistant Examiner(s): KAHELIN, MICHAEL WILLIAM
• Application Number:
  US10/426,284
• Publication Number:
  US 20040220630A1
• Time in Patent Office: 2,267 Days
• Field of Search: 607 4- 15, 607/25
• US Class Current: 607/5
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/3987 characterised by the timing or triggering of the shock

Abstract

An implantable medical device system and method are provided for synchronizing atrial cardioversion shocks to the ventricular rhythm using an adjustable atrial cardioversion/defibrillation ventricular refractory period. Upon determining a need for an atrial shock therapy, the method determines if the ventricular rate meets synchronization criteria based on an upper ventricular refractory period limit. If synchronization criteria are not met, the refractory period is automatically adjusted in stepwise decrements until the synchronization criteria are met, or until a lower refractory period limit is exceeded. If synchronization criteria are met, an atrial shock is synchronized to the next ventricular depolarization occurring outside the current refractory period. If the lower refractory period limit is exceeded, the atrial therapy is aborted.

Claims

1. A method of controlling a therapy in an implantable medical device, comprising:

setting a refractory period upper limit;

setting a lower limit for the refractory period;

initializing a refractory period to the refractory period upper limit;

sensing a cardiac signal other than during the refractory period and determining whether to deliver a therapy in response to the cardiac signal;

determining whether an R-wave synchronization criteria for delivering the therapy are met; and

then

if the R-wave synchronization criteria are met, delivering the therapy and returning to the sensing step; and

if the R-wave synchronization criteria are not met, automatically adjusting the refractory period to be less than the refractory period upper limit and return to the sensing step;

determining whether the refractory period, as adjusted, is less than the lower limit;

terminating the method in response to the refractory period, as adjusted, being less than the lower limit;

determining, in response to the refractory period, as adjusted, not being less than the lower limit, whether the R-wave synchronization criteria corresponding to the refractory period, as adjusted, are met for a subsequently sensed cardiac signal;

delivering the therapy in response to the R-wave synchronization criteria being met for the subsequently sensed cardiac signals; and

automatically adjusting the refractory period, as adjusted, in response to the R-wave synchronization criteria not being met.

2. The method of claim 1, wherein determining whether R-wave synchronization criteria are met further comprises determining whether a predetermined number of intervals corresponding to the cardiac signal are greater than or equal to the refractory period.

3. The method of claim 1, wherein automatically adjusting the refractory period further comprises decreasing the refractory period by a predetermined interval.

4. The method of claim 1, wherein delivering the therapy further comprises synchronizing the delivery of the therapy to a next interval corresponding to the cardiac signal greater than the refractory period.

5. The method of claim 1, wherein the refractory period has an upper limit and a lower limit, and wherein determining whether R-wave synchronization criteria are met comprises determining whether a predetermined number of intervals corresponding to the cardiac signal are within the upper limit and the lower limit.

6. The method of claim 5, wherein the delivered therapy corresponds to an atrial shock therapy.

7. The method of claim 6, further comprising determining whether sensed cardiac signals subsequent to the delivered therapy correspond to ventricular arrhythmia, and resetting the lower limit in response to the cardiac signal subsequent to the delivered therapy corresponding to ventricular arrhythmia.

8. The method of claim 6, further comprising verifying a stable ventricular rhythm prior to delivering the therapy.

9. An implantable medical device, comprising:

means for setting a refractory period upper limit;

means for initializing a refractory period to the refractory period upper limit;

means for sensing cardiac signals other than during the refractory period and determining whether to deliver a therapy in response to the sensed cardiac signals;

means for determining whether R-wave synchronization criteria for delivering the therapy are met;

means for delivering the therapy in response to the synchronization criteria being met; and

means for automatically adjusting the refractory period in response to the synchronization criteria not being met;

means for setting a lower limit for the refractory period and wherein the determining means determines whether the refractory period, as adjusted, is less than a lower limit, and determines, in response to the refractory period, as adjusted, not being less than the lower limit, whether the synchronization criteria corresponding to the refractory period, as adjusted, are met for subsequently sensed cardiac signals, the delivery means delivers the therapy in response to the synchronization criteria being met for the subsequently sensed cardiac signals, and the adjusting means adjusts the refractory period, as adjusted, in response to the synchronization criteria not being met.

10. The device of claim 9, wherein the determining means determines whether the synchronization criteria corresponding to the refractory period, as adjusted, are met for subsequently sensed cardiac signals, the delivering means delivers the therapy in response to the synchronization criteria being met for the subsequently sensed cardiac signals, and the adjusting means automatically adjusts the refractory period, as adjusted in response to the synchronization criteria not being met.

11. The device of claim 9, wherein the determining means determines whether a predetermined number of intervals corresponding to the sensed cardiac signals are greater than or equal to the refractory period.

12. The device of claim 9, wherein the adjusting means decreases the refractory period by a predetermined interval.

13. The device of claim 9, wherein the delivering means synchronizes the delivery of the therapy to a next interval corresponding to the sensed cardiac signals greater than the refractory period.

14. The device of claim 9, wherein the refractory period has an upper limit and a lower limit, the determining means determines whether a predetermined number of intervals corresponding to the sensed cardiac signals are within the upper limit and the lower limit, and the adjusting means decreases the refractory period.

15. The device of claim 14, wherein the delivered therapy corresponds to an atrial shock therapy.

16. The device of claim 15, further comprising means for determining whether sensed cardiac signals subsequent to the delivered therapy correspond to ventricular arrhythmia, and resetting the lower limit in response to sensed cardiac signals subsequent to the delivered therapy corresponding to ventricular arrhythmia.

17. The device of claim 15, further comprising means for verifying a stable ventricular rhythm prior to delivering the therapy.